Reduced CA2-CA3 hippocampal subfield volume is related to depression and normalized by L-DOPA in newly diagnosed Parkinson's disease

Orsolya Györfi, Helga Nagy, Magdolna Bokor, Ahmed A. Moustafa, Ivana Rosenzweig, O. Kelemen, S. Kéri

Research output: Article

6 Citations (Scopus)

Abstract

Hippocampal dysfunctions may play an important role in the non-motor aspects of Parkinson's disease (PD), including depressive and cognitive symptoms. Fine structural alterations of the hippocampus and their relationship with symptoms and medication effects are unknown in newly diagnosed PD. We measured the volume of hippocampal subfields in 35 drug-naïve, newly diagnosed PD patients without cognitive impairment and 30 matched healthy control individuals. Assessments were performed when the patients did not receive medications and after a 24-week period of l-DOPA treatment. We obtained a T1-weighted 3D magnetization-prepared rapid acquisition gradient echo image at each assessment. FreeSurfer v6.0 was used for image analysis. Results revealed a selectively decreased CA2-CA3 volume in non-medicated PD patients, which was normalized after the 24-week treatment period. Higher depressive symptoms were associated with smaller CA2-CA3 volumes. These results indicate that the CA2-CA3 subfield is structurally affected in the earliest stage of PD in the absence of cognitive impairment. This structural anomaly, normalized by l-DOPA, is related to depressive non-motor symptoms.

Original languageEnglish
Article number84
JournalFrontiers in Neurology
Volume8
Issue numberMAR
DOIs
Publication statusPublished - márc. 17 2017

Fingerprint

Parkinson Disease
Depression
Neurobehavioral Manifestations
Hippocampus
Therapeutics
Pharmaceutical Preparations
Cognitive Dysfunction

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Reduced CA2-CA3 hippocampal subfield volume is related to depression and normalized by L-DOPA in newly diagnosed Parkinson's disease. / Györfi, Orsolya; Nagy, Helga; Bokor, Magdolna; Moustafa, Ahmed A.; Rosenzweig, Ivana; Kelemen, O.; Kéri, S.

In: Frontiers in Neurology, Vol. 8, No. MAR, 84, 17.03.2017.

Research output: Article

Györfi, Orsolya ; Nagy, Helga ; Bokor, Magdolna ; Moustafa, Ahmed A. ; Rosenzweig, Ivana ; Kelemen, O. ; Kéri, S. / Reduced CA2-CA3 hippocampal subfield volume is related to depression and normalized by L-DOPA in newly diagnosed Parkinson's disease. In: Frontiers in Neurology. 2017 ; Vol. 8, No. MAR.
@article{077b1a9e6a4246bc81dd24bf7679be1d,
title = "Reduced CA2-CA3 hippocampal subfield volume is related to depression and normalized by L-DOPA in newly diagnosed Parkinson's disease",
abstract = "Hippocampal dysfunctions may play an important role in the non-motor aspects of Parkinson's disease (PD), including depressive and cognitive symptoms. Fine structural alterations of the hippocampus and their relationship with symptoms and medication effects are unknown in newly diagnosed PD. We measured the volume of hippocampal subfields in 35 drug-na{\"i}ve, newly diagnosed PD patients without cognitive impairment and 30 matched healthy control individuals. Assessments were performed when the patients did not receive medications and after a 24-week period of l-DOPA treatment. We obtained a T1-weighted 3D magnetization-prepared rapid acquisition gradient echo image at each assessment. FreeSurfer v6.0 was used for image analysis. Results revealed a selectively decreased CA2-CA3 volume in non-medicated PD patients, which was normalized after the 24-week treatment period. Higher depressive symptoms were associated with smaller CA2-CA3 volumes. These results indicate that the CA2-CA3 subfield is structurally affected in the earliest stage of PD in the absence of cognitive impairment. This structural anomaly, normalized by l-DOPA, is related to depressive non-motor symptoms.",
keywords = "Depression, Hippocampus, L-DOPA, MRI, Parkinson's disease",
author = "Orsolya Gy{\"o}rfi and Helga Nagy and Magdolna Bokor and Moustafa, {Ahmed A.} and Ivana Rosenzweig and O. Kelemen and S. K{\'e}ri",
year = "2017",
month = "3",
day = "17",
doi = "10.3389/fneur.2017.00084",
language = "English",
volume = "8",
journal = "Frontiers in Neurology",
issn = "1664-2295",
publisher = "Frontiers Research Foundation",
number = "MAR",

}

TY - JOUR

T1 - Reduced CA2-CA3 hippocampal subfield volume is related to depression and normalized by L-DOPA in newly diagnosed Parkinson's disease

AU - Györfi, Orsolya

AU - Nagy, Helga

AU - Bokor, Magdolna

AU - Moustafa, Ahmed A.

AU - Rosenzweig, Ivana

AU - Kelemen, O.

AU - Kéri, S.

PY - 2017/3/17

Y1 - 2017/3/17

N2 - Hippocampal dysfunctions may play an important role in the non-motor aspects of Parkinson's disease (PD), including depressive and cognitive symptoms. Fine structural alterations of the hippocampus and their relationship with symptoms and medication effects are unknown in newly diagnosed PD. We measured the volume of hippocampal subfields in 35 drug-naïve, newly diagnosed PD patients without cognitive impairment and 30 matched healthy control individuals. Assessments were performed when the patients did not receive medications and after a 24-week period of l-DOPA treatment. We obtained a T1-weighted 3D magnetization-prepared rapid acquisition gradient echo image at each assessment. FreeSurfer v6.0 was used for image analysis. Results revealed a selectively decreased CA2-CA3 volume in non-medicated PD patients, which was normalized after the 24-week treatment period. Higher depressive symptoms were associated with smaller CA2-CA3 volumes. These results indicate that the CA2-CA3 subfield is structurally affected in the earliest stage of PD in the absence of cognitive impairment. This structural anomaly, normalized by l-DOPA, is related to depressive non-motor symptoms.

AB - Hippocampal dysfunctions may play an important role in the non-motor aspects of Parkinson's disease (PD), including depressive and cognitive symptoms. Fine structural alterations of the hippocampus and their relationship with symptoms and medication effects are unknown in newly diagnosed PD. We measured the volume of hippocampal subfields in 35 drug-naïve, newly diagnosed PD patients without cognitive impairment and 30 matched healthy control individuals. Assessments were performed when the patients did not receive medications and after a 24-week period of l-DOPA treatment. We obtained a T1-weighted 3D magnetization-prepared rapid acquisition gradient echo image at each assessment. FreeSurfer v6.0 was used for image analysis. Results revealed a selectively decreased CA2-CA3 volume in non-medicated PD patients, which was normalized after the 24-week treatment period. Higher depressive symptoms were associated with smaller CA2-CA3 volumes. These results indicate that the CA2-CA3 subfield is structurally affected in the earliest stage of PD in the absence of cognitive impairment. This structural anomaly, normalized by l-DOPA, is related to depressive non-motor symptoms.

KW - Depression

KW - Hippocampus

KW - L-DOPA

KW - MRI

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=85016146388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016146388&partnerID=8YFLogxK

U2 - 10.3389/fneur.2017.00084

DO - 10.3389/fneur.2017.00084

M3 - Article

VL - 8

JO - Frontiers in Neurology

JF - Frontiers in Neurology

SN - 1664-2295

IS - MAR

M1 - 84

ER -